TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP206	Fatty Acid Omega Oxidation	4.28205558690032e-05	-10.0584922933596	15	5	0.0328947368421053	152	5311	126,216,127,125,130	ADH1C,ALDH1A1,ADH4,ADH1B,ADH6
WP383	Striated Muscle Contraction	0.000644177503192491	-7.34753624376251	38	6	0.0394736842105263	152	5311	10398,7140,4634,7136,70,4632	MYL9,TNNT3,MYL3,TNNI2,ACTC1,MYL1
WP474	Endochondral Ossification	0.00237118276273297	-6.04436639231666	65	7	0.0460526315789474	152	5311	55553,4256,579,3549,5167,1028,5745	SOX6,MGP,NKX3-2,IHH,ENPP1,CDKN1C,PTH1R
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.00768831584856602	-4.8680535248378	5	2	0.0131578947368421	152	5311	2326,2327	FMO1,FMO2
WP716	Vitamin A and Carotenoid Metabolism	0.00793927380404678	-4.83593346835336	44	5	0.0328947368421053	152	5311	127,216,29881,948,6017	ADH4,ALDH1A1,NPC1L1,CD36,RLBP1
WP408	Oxidative Stress	0.0111189262638108	-4.49910655383164	31	4	0.0263157894736842	152	5311	2878,2953,6648,50507	GPX3,GSTT2,SOD2,NOX4
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.0116381176243683	-4.45346956587587	17	3	0.0197368421052632	152	5311	788,55825,33	SLC25A20,PECR,ACADL
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.0136772141270774	-4.2920240332078	18	3	0.0197368421052632	152	5311	4256,3714,55553	MGP,JAG2,SOX6
WP3925	Amino Acid metabolism	0.0148879997066246	-4.20719977934769	91	7	0.0460526315789474	152	5311	151742,3158,5105,127,126,216,5166	PPM1L,HMGCS2,PCK1,ADH4,ADH1C,ALDH1A1,PDK4
WP2406	Cardiac Progenitor Differentiation	0.0170945166624372	-4.06899752991227	53	5	0.0328947368421053	152	5311	22943,3815,4684,9241,70	DKK1,KIT,NCAM1,NOG,ACTC1
WP1589	Folate-Alcohol and Cancer Pathway	0.0203442590940496	-3.8949565152941	8	2	0.0131578947368421	152	5311	216,10840	ALDH1A1,ALDH1L1
WP100	Glutathione metabolism	0.023751646972059	-3.74010340471386	22	3	0.0197368421052632	152	5311	2878,2953,2946	GPX3,GSTT2,GSTM2
WP51	Regulation of Actin Cytoskeleton	0.0263523356379196	-3.63619836891274	149	9	0.0592105263157895	152	5311	55740,2149,4634,5295,4632,929,2147,2252,4638	ENAH,F2R,MYL3,PIK3R1,MYL1,CD14,F2,FGF7,MYLK
WP61	Notch Signaling Pathway	0.0314525765360725	-3.45927437435597	62	5	0.0328947368421053	152	5311	2625,3714,5295,4137,2273	GATA3,JAG2,PIK3R1,MAPT,FHL1
WP2865	IL1 and megakaryocytes in obesity	0.0333379947231763	-3.40105754974381	25	3	0.0197368421052632	152	5311	2147,8991,2149	F2,SELENBP1,F2R
WP176	Folate Metabolism	0.0466781812639015	-3.06447843410727	69	5	0.0328947368421053	152	5311	2147,4353,338,6648,2878	F2,MPO,APOB,SOD2,GPX3
WP2848	Differentiation Pathway	0.0474245631056583	-3.04861497552488	48	4	0.0263157894736842	152	5311	9241,22943,3815,8200	NOG,DKK1,KIT,GDF5
WP2881	Estrogen Receptor Pathway	0.0516241268141722	-2.96376614185518	13	2	0.0131578947368421	152	5311	5105,5166	PCK1,PDK4
WP2855	Dopaminergic Neurogenesis	0.0530974426511275	-2.93562651288974	30	3	0.0197368421052632	152	5311	216,1028,2735	ALDH1A1,CDKN1C,GLI1
WP24	Peptide GPCRs	0.0598322292749416	-2.81621081212155	74	5	0.0328947368421053	152	5311	4987,886,6755,2359,10396	OPRL1,CCKAR,SSTR5,FPR3,ATP8A1
WP1533	Vitamin B12 Metabolism	0.0640643824472672	-2.74786672553842	53	4	0.0263157894736842	152	5311	2147,4353,338,6648	F2,MPO,APOB,SOD2
WP702	Metapathway biotransformation	0.066246774718447	-2.71436849879602	177	9	0.0592105263157895	152	5311	2946,2953,2878,7881,66002,51302,260293,2326,2327	GSTM2,GSTT2,GPX3,KCNAB1,CYP4F12,CYP39A1,CYP4X1,FMO1,FMO2
WP47	Hedgehog Signaling Pathway	0.0751379816528484	-2.58842910035161	16	2	0.0131578947368421	152	5311	3549,2735	IHH,GLI1
WP236	Adipogenesis	0.0806864126932075	-2.51718508599565	131	7	0.0460526315789474	152	5311	2625,2662,5105,6424,1271,5740,3399	GATA3,GDF10,PCK1,SFRP4,CNTFR,PTGIS,ID3
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.092345557197616	-2.38221768180365	18	2	0.0131578947368421	152	5311	6424,8325	SFRP4,FZD8
WP15	Selenium Micronutrient Network	0.102868353630884	-2.27430522833313	87	5	0.0328947368421053	152	5311	2878,338,6648,2147,4353	GPX3,APOB,SOD2,F2,MPO
WP1603	Nicotine Activity on Chromaffin Cells	0.109687555741024	-2.2101193571418	4	1	0.00657894736842105	152	5311	775	CACNA1C
WP49	IL-2 Signaling Pathway	0.117687455850171	-2.13972284770943	42	3	0.0197368421052632	152	5311	5295,4137,1154	PIK3R1,MAPT,CISH
WP311	Synthesis and Degradation of Ketone Bodies	0.135187365716255	-2.00109356858415	5	1	0.00657894736842105	152	5311	3158	HMGCS2
WP35	G Protein Signaling Pathways	0.135313776224866	-2.00015892914488	95	5	0.0328947368421053	152	5311	8622,5136,107,2788,27115	PDE8B,PDE1A,ADCY1,GNG7,PDE7B
WP536	Calcium Regulation in the Cardiac Cell	0.140869639809493	-1.95992035661322	151	7	0.0460526315789474	152	5311	2788,816,845,6546,775,107,482	GNG7,CAMK2B,CASQ2,SLC8A1,CACNA1C,ADCY1,ATP1B2
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.159457408327538	-1.83597842484598	25	2	0.0131578947368421	152	5311	285,1490	ANGPT2,CCN2
WP3891	Benzene metabolism	0.159961493195106	-1.83282216024398	6	1	0.00657894736842105	152	5311	4353	MPO
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.161048035177071	-1.82605260335963	74	4	0.0263157894736842	152	5311	816,22943,1028,51196	CAMK2B,DKK1,CDKN1C,PLCE1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.166984822826116	-1.78985235197608	102	5	0.0328947368421053	152	5311	5330,5608,1154,4638,5295	PLCB2,MAP2K6,CISH,MYLK,PIK3R1
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.172198063769206	-1.75910993113299	76	4	0.0263157894736842	152	5311	6444,775,6546,6445	SGCD,CACNA1C,SLC8A1,SGCG
WP3845	Canonical  and Non-canonical Notch signaling	0.179987876342137	-1.71486578401508	27	2	0.0131578947368421	152	5311	3714,4237	JAG2,MFAP2
WP422	MAPK Cascade	0.200889806010258	-1.60499875006011	29	2	0.0131578947368421	152	5311	5608,7786	MAP2K6,MAP3K12
WP455	GPCRs, Class A Rhodopsin-like	0.206422882949651	-1.5778283845159	259	10	0.0657894736842105	152	5311	56656,2359,27334,886,51554,4987,2857,2825,2149,6755	OR2S2,FPR3,P2RY10,CCKAR,ACKR4,OPRL1,GPR34,GPR1,F2R,SSTR5
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.207729814787234	-1.5715170110393	55	3	0.0197368421052632	152	5311	5295,5608,54	PIK3R1,MAP2K6,ACP5
WP2828	Bladder Cancer	0.232709467775586	-1.45796452288539	32	2	0.0131578947368421	152	5311	7057,5295	THBS1,PIK3R1
WP3893	Development and heterogeneity of the ILC family	0.232709467775586	-1.45796452288539	32	2	0.0131578947368421	152	5311	9760,2625	TOX,GATA3
WP2197	Endothelin Pathways	0.243393280473582	-1.41307670573838	33	2	0.0131578947368421	152	5311	4632,4638	MYL1,MYLK
WP3676	BDNF-TrkB Signaling	0.243393280473582	-1.41307670573838	33	2	0.0131578947368421	152	5311	2549,107	GAB1,ADCY1
WP558	Complement and Coagulation Cascades	0.245726497826355	-1.40353615900888	60	3	0.0197368421052632	152	5311	2147,2149,730	F2,F2R,C7
WP304	Kit receptor signaling pathway	0.245726497826355	-1.40353615900888	60	3	0.0197368421052632	152	5311	5295,4137,3815	PIK3R1,MAPT,KIT
WP3601	Composition of Lipid Particles	0.252203004568355	-1.37752094208709	10	1	0.00657894736842105	152	5311	338	APOB
WP143	Fatty Acid Beta Oxidation	0.254097841385687	-1.37003588382911	34	2	0.0131578947368421	152	5311	788,33	SLC25A20,ACADL
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.264813282603365	-1.32873029528846	35	2	0.0131578947368421	152	5311	5244,225	ABCB4,ABCD2
WP244	Alpha 6 Beta 4 signaling pathway	0.264813282603365	-1.32873029528846	35	2	0.0131578947368421	152	5311	5295,2549	PIK3R1,GAB1
WP3624	Lung fibrosis	0.269033795619133	-1.31291827299975	63	3	0.0197368421052632	152	5311	2252,26585,1490	FGF7,GREM1,CCN2
WP43	Oxidation by Cytochrome P450	0.269033795619133	-1.31291827299975	63	3	0.0197368421052632	152	5311	260293,66002,51302	CYP4X1,CYP4F12,CYP39A1
WP500	Glycogen Metabolism	0.275530276923095	-1.28905775834006	36	2	0.0131578947368421	152	5311	8908,5260	GYG2,PHKG1
WP106	Alanine and aspartate metabolism	0.294476519448706	-1.22255600929423	12	1	0.00657894736842105	152	5311	2875	GPT
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.294476519448706	-1.22255600929423	12	1	0.00657894736842105	152	5311	5608	MAP2K6
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.294476519448706	-1.22255600929423	12	1	0.00657894736842105	152	5311	9241	NOG
WP2007	Iron metabolism in placenta	0.294476519448706	-1.22255600929423	12	1	0.00657894736842105	152	5311	30061	SLC40A1
WP2447	Amyotrophic lateral sclerosis (ALS)	0.296934185270131	-1.21424476315306	38	2	0.0131578947368421	152	5311	5630,5608	PRPH,MAP2K6
WP289	Myometrial Relaxation and Contraction Pathways	0.298261191233146	-1.20978569571346	158	6	0.0394736842105263	152	5311	816,2788,6546,107,70,10268	CAMK2B,GNG7,SLC8A1,ADCY1,ACTC1,RAMP3
WP23	B Cell Receptor Signaling Pathway	0.307987157162937	-1.17769719440086	98	4	0.0263157894736842	152	5311	5608,974,5295,2549	MAP2K6,CD79B,PIK3R1,GAB1
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.30836895633668	-1.17645830274646	68	3	0.0197368421052632	152	5311	8325,4632,4638	FZD8,MYL1,MYLK
WP481	Insulin Signaling	0.313427123964821	-1.1601884053744	161	6	0.0394736842105263	152	5311	7786,5167,5608,2549,5295,115703	MAP3K12,ENPP1,MAP2K6,GAB1,PIK3R1,ARHGAP33
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.314714218831761	-1.15609029375337	13	1	0.00657894736842105	152	5311	22943	DKK1
WP127	IL-5 Signaling Pathway	0.318244927650198	-1.1449339799271	40	2	0.0131578947368421	152	5311	5295,4137	PIK3R1,MAPT
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.32656762031276	-1.11911824508519	132	5	0.0328947368421053	152	5311	5105,5295,5608,53919,7786	PCK1,PIK3R1,MAP2K6,SLCO1C1,MAP3K12
WP322	Osteoblast Signaling	0.334375117043488	-1.09549181129533	14	1	0.00657894736842105	152	5311	5745	PTH1R
WP2636	Common Pathways Underlying Drug Addiction	0.339405159249782	-1.08056072520803	42	2	0.0131578947368421	152	5311	2891,107	GRIA2,ADCY1
WP364	IL-6 signaling pathway	0.34991275705896	-1.05007142111632	43	2	0.0131578947368421	152	5311	2549,5295	GAB1,PIK3R1
WP3	Transcriptional activation by NRF2	0.353475547897445	-1.03994096747376	15	1	0.00657894736842105	152	5311	4094	MAF
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	5105	PCK1
WP53	ID signaling pathway	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	3399	ID3
WP12	Osteoclast Signaling	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	54	ACP5
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	54843	SYTL2
WP550	Biogenic Amine Synthesis	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	5053	PAH
WP1946	Cori Cycle	0.372031385650004	-0.988777058241047	16	1	0.00657894736842105	152	5311	2875	GPT
WP465	Tryptophan metabolism	0.381077575355613	-0.964752314723859	46	2	0.0131578947368421	152	5311	216,66002	ALDH1A1,CYP4F12
WP28	Selenium Metabolism and Selenoproteins	0.381077575355613	-0.964752314723859	46	2	0.0131578947368421	152	5311	2878,8991	GPX3,SELENBP1
WP3874	Canonical and Non-Canonical TGF-B signaling	0.390058057863342	-0.941459684621674	17	1	0.00657894736842105	152	5311	26585	GREM1
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.395413344102519	-0.927823620452618	144	5	0.0328947368421053	152	5311	2891,84894,4684,5295,4137	GRIA2,LINGO1,NCAM1,PIK3R1,MAPT
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.407570557901435	-0.897541213065264	18	1	0.00657894736842105	152	5311	5608	MAP2K6
WP534	Glycolysis and Gluconeogenesis	0.411603142605305	-0.887695639955897	49	2	0.0131578947368421	152	5311	5105,5224	PCK1,PGAM2
WP286	IL-3 Signaling Pathway	0.411603142605305	-0.887695639955897	49	2	0.0131578947368421	152	5311	5169,5295	ENPP3,PIK3R1
WP2059	Alzheimers Disease	0.418339838945014	-0.871461164942301	148	5	0.0328947368421053	152	5311	6622,775,4137,5330,2905	SNCA,CACNA1C,MAPT,PLCB2,GRIN2C
WP697	Estrogen metabolism	0.42458345705169	-0.856646691725665	19	1	0.00657894736842105	152	5311	415	ARSE
WP1992	TarBasePathway	0.42458345705169	-0.856646691725665	19	1	0.00657894736842105	152	5311	2078	ERG
WP22	IL-9 Signaling Pathway	0.42458345705169	-0.856646691725665	19	1	0.00657894736842105	152	5311	5295	PIK3R1
WP2879	Farnesoid X Receptor  Pathway	0.42458345705169	-0.856646691725665	19	1	0.00657894736842105	152	5311	5244	ABCB4
WP2261	Signaling Pathways in Glioblastoma	0.426013292282688	-0.853284730658034	83	3	0.0197368421052632	152	5311	5608,5295,2549	MAP2K6,PIK3R1,GAB1
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.431542948850815	-0.840388239574473	51	2	0.0131578947368421	152	5311	5608,2252	MAP2K6,FGF7
WP516	Hypertrophy Model	0.441110916331522	-0.818458924203037	20	1	0.00657894736842105	152	5311	3491	CCN1
WP497	Urea cycle and metabolism of amino groups	0.441110916331522	-0.818458924203037	20	1	0.00657894736842105	152	5311	2593	GAMT
WP1602	Nicotine Activity on Dopaminergic Neurons	0.457166697983807	-0.782707188769914	21	1	0.00657894736842105	152	5311	84152	PPP1R1B
WP691	Tamoxifen metabolism	0.457166697983807	-0.782707188769914	21	1	0.00657894736842105	152	5311	2326	FMO1
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.457166697983807	-0.782707188769914	21	1	0.00657894736842105	152	5311	2252	FGF7
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.460769281725296	-0.774857834745062	54	2	0.0131578947368421	152	5311	7057,2149	THBS1,F2R
WP2857	Mesodermal Commitment Pathway	0.463718798942102	-0.768476947233101	156	5	0.0328947368421053	152	5311	9760,22943,8325,2625,9241	TOX,DKK1,FZD8,GATA3,NOG
WP395	IL-4 Signaling Pathway	0.470317940855449	-0.754346343075455	55	2	0.0131578947368421	152	5311	5295,2625	PIK3R1,GATA3
WP585	Interferon type I signaling pathways	0.470317940855449	-0.754346343075455	55	2	0.0131578947368421	152	5311	5608,5295	MAP2K6,PIK3R1
WP357	Fatty Acid Biosynthesis	0.472764176611768	-0.749158584348463	22	1	0.00657894736842105	152	5311	55825	PECR
WP272	Blood Clotting Cascade	0.472764176611768	-0.749158584348463	22	1	0.00657894736842105	152	5311	2147	F2
WP545	Complement Activation	0.472764176611768	-0.749158584348463	22	1	0.00657894736842105	152	5311	730	C7
WP167	Eicosanoid Synthesis	0.472764176611768	-0.749158584348463	22	1	0.00657894736842105	152	5311	5740	PTGIS
WP1424	Globo Sphingolipid Metabolism	0.472764176611768	-0.749158584348463	22	1	0.00657894736842105	152	5311	256435	ST6GALNAC3
WP306	Focal Adhesion	0.488103579879917	-0.717227641799363	195	6	0.0394736842105263	152	5311	5608,4638,5295,80310,7143,7057	MAP2K6,MYLK,PIK3R1,PDGFD,TNR,THBS1
WP195	IL-1 signaling pathway	0.489110998660072	-0.715165824140961	57	2	0.0131578947368421	152	5311	5608,5295	MAP2K6,PIK3R1
WP560	TGF-beta Receptor Signaling	0.498351436775555	-0.696449754507602	58	2	0.0131578947368421	152	5311	9241,7057	NOG,THBS1
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.502635849795066	-0.687889327735424	24	1	0.00657894736842105	152	5311	22943	DKK1
WP334	GPCRs, Class B Secretin-like	0.502635849795066	-0.687889327735424	24	1	0.00657894736842105	152	5311	5745	PTH1R
WP3527	Preimplantation Embryo	0.516511669342705	-0.660657397564973	60	2	0.0131578947368421	152	5311	2625,360	GATA3,AQP3
WP2895	Differentiation of white and brown adipocyte	0.516934951516607	-0.659838231506411	25	1	0.00657894736842105	152	5311	1149	CIDEA
WP205	IL-7 Signaling Pathway	0.516934951516607	-0.659838231506411	25	1	0.00657894736842105	152	5311	5295	PIK3R1
WP26	Signal Transduction of S1P Receptor	0.530825584773875	-0.633321777282757	26	1	0.00657894736842105	152	5311	5330	PLCB2
WP581	EPO Receptor Signaling	0.530825584773875	-0.633321777282757	26	1	0.00657894736842105	152	5311	1154	CISH
WP3584	MECP2 and Associated Rett Syndrome	0.534235162320696	-0.626919158082553	62	2	0.0131578947368421	152	5311	2593,1749	GAMT,DLX5
WP382	MAPK Signaling Pathway	0.540329093606518	-0.615576892447788	170	5	0.0328947368421053	152	5311	4068,7786,5608,4137,929	SH2D1A,MAP3K12,MAP2K6,MAPT,CD14
WP3594	Circadian rythm related genes	0.547216322872723	-0.602911083307434	207	6	0.0394736842105263	152	5311	4987,1628,107,3399,5593,6097	OPRL1,DBP,ADCY1,ID3,PRKG2,RORC
WP2249	Metastatic brain tumor	0.557427491896684	-0.584422843484462	28	1	0.00657894736842105	152	5311	5295	PIK3R1
WP2374	Oncostatin M Signaling Pathway	0.56833912635273	-0.565036984988572	66	2	0.0131578947368421	152	5311	5295,3491	PIK3R1,CCN1
WP3613	Photodynamic therapy-induced unfolded protein response	0.570160980675351	-0.561836535789737	29	1	0.00657894736842105	152	5311	121506	ERP27
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.570160980675351	-0.561836535789737	29	1	0.00657894736842105	152	5311	5133	PDCD1
WP185	Integrin-mediated Cell Adhesion	0.57024579320463	-0.561687794952032	103	3	0.0197368421052632	152	5311	827,5608,11131	CAPN6,MAP2K6,CAPN11
WP75	Toll-like Receptor Signaling Pathway	0.57024579320463	-0.561687794952032	103	3	0.0197368421052632	152	5311	929,5295,5608	CD14,PIK3R1,MAP2K6
WP98	Prostaglandin Synthesis and Regulation	0.582530448862006	-0.540373822183979	30	1	0.00657894736842105	152	5311	5740	PTGIS
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.582530448862006	-0.540373822183979	30	1	0.00657894736842105	152	5311	5295	PIK3R1
WP241	One Carbon Metabolism	0.582530448862006	-0.540373822183979	30	1	0.00657894736842105	152	5311	10840	ALDH1L1
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.584708864805484	-0.536641222626776	68	2	0.0131578947368421	152	5311	5608,5295	MAP2K6,PIK3R1
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.584708864805484	-0.536641222626776	68	2	0.0131578947368421	152	5311	5295,285	PIK3R1,ANGPT2
WP2884	NRF2 pathway	0.590258071812565	-0.527195427866368	143	4	0.0263157894736842	152	5311	2042,2946,2953,2878	EPHA3,GSTM2,GSTT2,GPX3
WP428	Wnt Signaling Pathway	0.600619946439021	-0.509792913130194	70	2	0.0131578947368421	152	5311	8325,6424	FZD8,SFRP4
WP1449	Regulation of toll-like receptor signaling pathway	0.601347653092934	-0.508582053963759	145	4	0.0263157894736842	152	5311	1154,5608,5295,929	CISH,MAP2K6,PIK3R1,CD14
WP453	Inflammatory Response Pathway	0.617556674461192	-0.481984434187623	33	1	0.00657894736842105	152	5311	7057	THBS1
WP430	Statin Pathway	0.617556674461192	-0.481984434187623	33	1	0.00657894736842105	152	5311	338	APOB
WP1601	Fluoropyrimidine Activity	0.628570578499074	-0.464306960519848	34	1	0.00657894736842105	152	5311	2030	SLC29A1
WP313	Signaling of Hepatocyte Growth Factor Receptor	0.628570578499074	-0.464306960519848	34	1	0.00657894736842105	152	5311	2549	GAB1
WP400	p38 MAPK Signaling Pathway	0.628570578499074	-0.464306960519848	34	1	0.00657894736842105	152	5311	5608	MAP2K6
WP2034	Leptin signaling pathway	0.645601891312772	-0.437572232487982	76	2	0.0131578947368421	152	5311	1154,5295	CISH,PIK3R1
WP2037	Prolactin Signaling Pathway	0.645601891312772	-0.437572232487982	76	2	0.0131578947368421	152	5311	5295,1154	PIK3R1,CISH
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.659756918071205	-0.415883817755681	37	1	0.00657894736842105	152	5311	285	ANGPT2
WP2526	PDGF Pathway	0.669562937887272	-0.401130110969435	38	1	0.00657894736842105	152	5311	5295	PIK3R1
WP170	Nuclear Receptors	0.679088148091661	-0.387004339390388	39	1	0.00657894736842105	152	5311	6097	RORC
WP524	G13 Signaling Pathway	0.688340538367567	-0.373471594947814	40	1	0.00657894736842105	152	5311	4632	MYL1
WP2911	miRNA targets in ECM and membrane receptors	0.714537336135875	-0.336120028063705	43	1	0.00657894736842105	152	5311	7057	THBS1
WP2332	Interleukin-11 Signaling Pathway	0.722773920211048	-0.324658802526742	44	1	0.00657894736842105	152	5311	5295	PIK3R1
WP1971	Integrated Cancer Pathway	0.738545408928363	-0.303072690846361	46	1	0.00657894736842105	152	5311	10811	NOXA1
WP268	Notch Signaling Pathway	0.738545408928363	-0.303072690846361	46	1	0.00657894736842105	152	5311	3714	JAG2
WP366	TGF-beta Signaling Pathway	0.74001616901726	-0.301083242999305	133	3	0.0197368421052632	152	5311	5608,5295,7057	MAP2K6,PIK3R1,THBS1
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	0.740581526740587	-0.300319554453222	91	2	0.0131578947368421	152	5311	2625,5295	GATA3,PIK3R1
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.746093575663186	-0.292904250099056	47	1	0.00657894736842105	152	5311	1154	CISH
WP2586	Aryl Hydrocarbon Receptor	0.753425220130474	-0.28312550919757	48	1	0.00657894736842105	152	5311	948	CD36
WP2849	Hematopoietic Stem Cell Differentiation	0.753425220130474	-0.28312550919757	48	1	0.00657894736842105	152	5311	4778	NFE2
WP1772	Apoptosis Modulation and Signaling	0.75676011983598	-0.278708958409922	94	2	0.0131578947368421	152	5311	79444,5414	BIRC7,SEPTIN4
WP2637	Structural Pathway of Interleukin 1 (IL-1)	0.767463451832456	-0.264664420416914	50	1	0.00657894736842105	152	5311	5608	MAP2K6
WP2853	Endoderm Differentiation	0.791265935698743	-0.234121165822932	145	3	0.0197368421052632	152	5311	9760,22943,9241	TOX,DKK1,NOG
WP673	ErbB Signaling Pathway	0.793201738970018	-0.231677689991423	54	1	0.00657894736842105	152	5311	2549	GAB1
WP3286	Copper homeostasis	0.793201738970018	-0.231677689991423	54	1	0.00657894736842105	152	5311	4137	MAPT
WP2064	Neural Crest Differentiation	0.795725269916816	-0.22850129100714	102	2	0.0131578947368421	152	5311	1749,2670	DLX5,GFAP
WP2272	Pathogenic Escherichia coli infection	0.799181068567523	-0.224167739906932	55	1	0.00657894736842105	152	5311	929	CD14
WP2795	Cardiac Hypertrophic Response	0.810629289340972	-0.209944432525617	57	1	0.00657894736842105	152	5311	5608	MAP2K6
WP615	Senescence and Autophagy in Cancer	0.813073440881865	-0.206933840326097	106	2	0.0131578947368421	152	5311	9547,7057	CXCL14,THBS1
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.836491589156273	-0.178538813410025	62	1	0.00657894736842105	152	5311	5133	PDCD1
WP710	DNA Damage Response (only ATM dependent)	0.843893130696166	-0.16972941480138	114	2	0.0131578947368421	152	5311	6648,5295	SOD2,PIK3R1
WP437	EGF/EGFR Signaling Pathway	0.849343538253497	-0.163291535818252	162	3	0.0197368421052632	152	5311	2549,5295,51196	GAB1,PIK3R1,PLCE1
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.849343538253497	-0.163291535818252	162	3	0.0197368421052632	152	5311	3764,2625,5053	KCNJ8,GATA3,PAH
WP2431	Spinal Cord Injury	0.860753957286379	-0.149946579287719	119	2	0.0131578947368421	152	5311	2670,50507	GFAP,NOX4
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.862933467709416	-0.147417685065966	68	1	0.00657894736842105	152	5311	5295	PIK3R1
WP45	G1 to S cell cycle control	0.862933467709416	-0.147417685065966	68	1	0.00657894736842105	152	5311	1028	CDKN1C
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.870766403528914	-0.138381531522523	70	1	0.00657894736842105	152	5311	6622	SNCA
WP2328	Allograft Rejection	0.903739784670429	-0.10121380884228	80	1	0.00657894736842105	152	5311	55825	PECR
WP2371	Parkinsons Disease Pathway	0.911891085475646	-0.0922347198599612	83	1	0.00657894736842105	152	5311	6622	SNCA
WP254	Apoptosis	0.919356291826777	-0.0840815366282785	86	1	0.00657894736842105	152	5311	5295	PIK3R1
WP2858	Ectoderm Differentiation	0.920809487323033	-0.0825021182793323	143	2	0.0131578947368421	152	5311	6622,8325	SNCA,FZD8
WP2377	Integrated Pancreatic Cancer Pathway	0.926507082888748	-0.0763335885058598	197	3	0.0197368421052632	152	5311	4137,10811,7057	MAPT,NOXA1,THBS1
WP138	Androgen receptor signaling pathway	0.928341153988468	-0.0743559909202526	90	1	0.00657894736842105	152	5311	5295	PIK3R1
WP111	Electron Transport Chain	0.932453241700511	-0.0699362716698801	92	1	0.00657894736842105	152	5311	7351	UCP2
WP231	TNF alpha Signaling Pathway	0.936330823990033	-0.0657864205175196	94	1	0.00657894736842105	152	5311	5608	MAP2K6
WP117	GPCRs, Other	0.938185858445021	-0.0638072062721302	95	1	0.00657894736842105	152	5311	2149	F2R
WP179	Cell Cycle	0.954023449572743	-0.0470670275710107	105	1	0.00657894736842105	152	5311	219972	MPEG1
WP399	Wnt Signaling Pathway and Pluripotency	0.955365830604712	-0.0456609431574546	106	1	0.00657894736842105	152	5311	8325	FZD8
WP1984	Integrated Breast Cancer Pathway	0.989309703157479	-0.0107478485968652	154	1	0.00657894736842105	152	5311	10811	NOXA1
WP3674	Tgif disruption of Shh signaling	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3300	Dual hijack model of Vif in HIV infection	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3297	EV release from cardiac cells and their functional effects	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP696	Benzo(a)pyrene metabolism	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3585	Cytosine methylation	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP561	Heme Biosynthesis	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP288	NLR Proteins	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3875	ATR Signaling	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP531	Mismatch repair	0.999999999996413	-3.58749099402614e-12	9	0	0	152	5311
WP3853	ERK Pathway in Huntington's Disease	0.999999999999953	-4.70133697344811e-14	14	0	0	152	5311
WP2436	Dopamine metabolism	0.999999999999953	-4.70133697344811e-14	14	0	0	152	5311
WP229	Irinotecan Pathway	0.999999999999953	-4.70133697344811e-14	14	0	0	152	5311
WP496	Steroid Biosynthesis	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP1531	Vitamin D Metabolism	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP2874	Liver X Receptor Pathway	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP704	Methylation Pathways	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP2113	Type III interferon signaling	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP2333	Trans-sulfuration pathway	1.00000000000343	3.42695750598435e-12	10	0	0	152	5311
WP1742	TP53 Network	1.00000000000344	3.4397338483578e-12	20	0	0	152	5311
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1.00000000000344	3.4397338483578e-12	20	0	0	152	5311
WP391	Mitochondrial Gene Expression	1.00000000000344	3.4397338483578e-12	20	0	0	152	5311
WP1422	Sphingolipid Metabolism	1.00000000000344	3.4397338483578e-12	20	0	0	152	5311
WP2533	Glycerophospholipid Biosynthetic Pathway	1.00000000000636	6.35930425270783e-12	21	0	0	152	5311
WP2507	Nanomaterial induced apoptosis	1.00000000000636	6.35930425270783e-12	21	0	0	152	5311
WP694	Arylamine metabolism	1.0000000000068	6.80033706123416e-12	6	0	0	152	5311
WP1981	Thyroxine (Thyroid Hormone) Production	1.0000000000068	6.80033706123416e-12	6	0	0	152	5311
WP1600	Nicotine Metabolism	1.0000000000068	6.80033706123416e-12	6	0	0	152	5311
WP2361	Gastric Cancer Network 1	1.00000000000722	7.21956564590736e-12	28	0	0	152	5311
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000729	7.28864572363389e-12	29	0	0	152	5311
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000741	7.41447850391537e-12	27	0	0	152	5311
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000772	7.7186104562731e-12	5	0	0	152	5311
WP2542	Sulindac Metabolic Pathway	1.00000000000772	7.7186104562731e-12	5	0	0	152	5311
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000772	7.7186104562731e-12	5	0	0	152	5311
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	1.00000000000772	7.7186104562731e-12	5	0	0	152	5311
WP3630	NAD metabolism, sirtuins and aging	1.00000000000787	7.87119904198684e-12	11	0	0	152	5311
WP1455	Serotonin Transporter Activity	1.00000000000787	7.87119904198684e-12	11	0	0	152	5311
WP2513	Nanoparticle triggered regulated necrosis	1.00000000000787	7.87119904198684e-12	11	0	0	152	5311
WP80	Nucleotide GPCRs	1.00000000000787	7.87119904198684e-12	11	0	0	152	5311
WP2854	Gene regulatory network modelling somitogenesis	1.00000000000787	7.87119904198684e-12	11	0	0	152	5311
WP1528	Physiological and Pathological Hypertrophy  of the Heart	1.0000000000079	7.8965351667289e-12	25	0	0	152	5311
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000000909	9.08796446097101e-12	3	0	0	152	5311
WP3408	Evolocumab Mechanism	1.00000000000909	9.08796446097101e-12	3	0	0	152	5311
WP3529	Zinc homeostasis	1.00000000000948	9.48135105008009e-12	37	0	0	152	5311
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000000948	9.48135105008009e-12	37	0	0	152	5311
WP619	Type II interferon signaling (IFNG)	1.00000000000948	9.48135105008009e-12	37	0	0	152	5311
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000000948	9.48135105008009e-12	37	0	0	152	5311
WP1272	Selenium Micronutrient Network	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP528	Acetylcholine Synthesis	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP2596	Gastric acid production	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP699	Aflatoxin B1 metabolism	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP3924	Hfe effect on hepcidin production	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP2805	RNA interference	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP134	Pentose Phosphate Pathway	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP438	Non-homologous end joining	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP1995	Effects of Nitric Oxide	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP1310	Selenium Micronutrient Network	1.00000000001112	1.11222251829544e-11	7	0	0	152	5311
WP3851	TLR4 Signaling and Tolerance	1.00000000001225	1.22522631391694e-11	30	0	0	152	5311
WP2870	Extracellular vesicle-mediated signaling in recipient cells	1.00000000001225	1.22522631391694e-11	30	0	0	152	5311
WP129	Matrix Metalloproteinases	1.00000000001225	1.22522631391694e-11	30	0	0	152	5311
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000001225	1.22530578755081e-11	48	0	0	152	5311
WP661	Glucose Homeostasis	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP2190	One carbon donor	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP188	Focal Adhesion	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP3627	Gut-Liver Indole Metabolism	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP108	Selenium metabolism/Selenoproteins	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP1	Statin Pathway	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP3191	TSLP Signaling Pathway	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP2536	Colchicine Metabolic Pathway	1.00000000001242	1.24155893899136e-11	1	0	0	152	5311
WP733	Serotonin Receptor 2 and STAT3 Signaling	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP3633	Caffeine and Theobromine metabolism	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP2491	Diclofenac Metabolic Pathway	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP690	Polyol Pathway	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP2889	Oxytocin signaling	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP2253	Pilocytic astrocytoma	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP521	Amino acid conjugation of benzoic acid	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP1133	Androgen receptor signaling pathway	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP897	Androgen receptor signaling pathway	1.0000000000125	1.25045471895727e-11	4	0	0	152	5311
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000001273	1.27319066313995e-11	18	0	0	152	5311
WP692	Sulfation Biotransformation Reaction	1.00000000001273	1.27319066313995e-11	18	0	0	152	5311
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP136	Phase I biotransformations, non P450	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP1604	Codeine and Morphine Metabolism	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP2338	miRNA Biogenesis	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP2276	Glial Cell Differentiation	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP3407	FTO Obesity Variant Mechanism	1.00000000001321	1.32125867551304e-11	8	0	0	152	5311
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000001362	1.36223919888204e-11	17	0	0	152	5311
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000001362	1.36223919888204e-11	17	0	0	152	5311
WP2289	Drug Induction of Bile Acid Pathway	1.00000000001362	1.36223919888204e-11	17	0	0	152	5311
WP554	ACE Inhibitor Pathway	1.00000000001362	1.36223919888204e-11	17	0	0	152	5311
WP78	TCA Cycle	1.00000000001362	1.36223919888204e-11	17	0	0	152	5311
WP3871	Valproic acid pathway	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP1423	Ganglio Sphingolipid Metabolism	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP1434	Osteopontin Signaling	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP186	Homologous recombination	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP3892	Development of pulmonary dendritic cells and macrophage subsets	1.00000000001493	1.49266985582785e-11	13	0	0	152	5311
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.00000000001572	1.57160229011841e-11	49	0	0	152	5311
WP3858	Toll-like Receptor Signaling	1.00000000001587	1.58738061000994e-11	32	0	0	152	5311
WP34	Ovarian Infertility Genes	1.00000000001587	1.58738061000994e-11	32	0	0	152	5311
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000001587	1.58738061000994e-11	32	0	0	152	5311
WP2875	Constitutive Androstane Receptor Pathway	1.00000000001587	1.58738061000994e-11	32	0	0	152	5311
WP727	Monoamine Transport	1.00000000001587	1.58738061000994e-11	32	0	0	152	5311
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	1.00000000001615	1.61507417942009e-11	23	0	0	152	5311
WP712	Estrogen signaling pathway	1.00000000001615	1.61507417942009e-11	23	0	0	152	5311
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP3287	Overview of nanoparticle effects	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP404	Nucleotide Metabolism	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP247	Small Ligand GPCRs	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP384	Apoptosis Modulation by HSP70	1.00000000001618	1.61763372921762e-11	19	0	0	152	5311
WP2878	PPAR Alpha Pathway	1.00000000001652	1.65155816885062e-11	26	0	0	152	5311
WP325	Triacylglyceride Synthesis	1.00000000001652	1.65155816885062e-11	26	0	0	152	5311
WP530	Cytokines and Inflammatory Response	1.00000000001652	1.65155816885062e-11	26	0	0	152	5311
WP698	Glucuronidation	1.00000000001652	1.65155816885062e-11	26	0	0	152	5311
WP1591	Heart Development	1.00000000001665	1.66461620225397e-11	46	0	0	152	5311
WP3878	ATM Signaling Network in Development and Disease	1.00000000001665	1.66461620225397e-11	46	0	0	152	5311
WP58	Monoamine GPCRs	1.00000000001679	1.67859518697439e-11	33	0	0	152	5311
WP2363	Gastric Cancer Network 2	1.00000000001679	1.67859518697439e-11	33	0	0	152	5311
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.0000000000168	1.67954945601073e-11	35	0	0	152	5311
WP1545	miRNAs involved in DNA damage response	1.00000000001683	1.68312689644109e-11	50	0	0	152	5311
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000001737	1.7366151410271e-11	51	0	0	152	5311
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	1.00000000001749	1.74949354399523e-11	44	0	0	152	5311
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000001752	1.75156501561782e-11	73	0	0	152	5311
WP2112	IL17 signaling pathway	1.00000000001797	1.7966725497463e-11	31	0	0	152	5311
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000001797	1.7966725497463e-11	31	0	0	152	5311
WP2866	mir34a and TGIF2 in osteoclastogenesis	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP1311	Folic Acid Network	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP2816	Felbamate Metabolism	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP1438	Influenza A virus infection	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP1273	Folic Acid Network	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP2366	Butyrate-induced histone acetylation	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP2943	Hypoxia-mediated EMT and Stemness	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP2646	Lidocaine metabolism	1.00000000001813	1.8125624699078e-11	2	0	0	152	5311
WP3644	NAD+ metabolism	1.00000000001861	1.86077043100556e-11	16	0	0	152	5311
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000001861	1.86077043100556e-11	16	0	0	152	5311
WP623	Oxidative phosphorylation	1.0000000000193	1.93010019073548e-11	54	0	0	152	5311
WP2012	miRs in Muscle Cell Differentiation	1.00000000001934	1.933896559607e-11	36	0	0	152	5311
WP3298	Melatonin metabolism and effects	1.00000000001934	1.933896559607e-11	36	0	0	152	5311
WP466	DNA Replication	1.00000000001949	1.94865095455886e-11	42	0	0	152	5311
WP405	Eukaryotic Transcription Initiation	1.00000000001949	1.94865095455886e-11	42	0	0	152	5311
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000001949	1.94865095455886e-11	42	0	0	152	5311
WP3599	Transcription factor regulation in adipogenesis	1.00000000002026	2.0260208721571e-11	22	0	0	152	5311
WP1584	Type II diabetes mellitus	1.00000000002026	2.0260208721571e-11	22	0	0	152	5311
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000002026	2.0260208721571e-11	22	0	0	152	5311
WP3645	NAD+ biosynthetic pathways	1.00000000002026	2.0260208721571e-11	22	0	0	152	5311
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000002026	2.0260208721571e-11	22	0	0	152	5311
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000002038	2.03764890488323e-11	15	0	0	152	5311
WP197	Cholesterol Biosynthesis	1.00000000002038	2.03764890488323e-11	15	0	0	152	5311
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000002046	2.04619227757737e-11	41	0	0	152	5311
WP183	Proteasome Degradation	1.00000000002051	2.05098009754247e-11	66	0	0	152	5311
WP2324	AGE/RAGE pathway	1.00000000002051	2.05098009754247e-11	66	0	0	152	5311
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.00000000002051	2.05098009754247e-11	66	0	0	152	5311
WP2267	Synaptic Vesicle Pathway	1.0000000000208	2.08004629009154e-11	52	0	0	152	5311
WP2509	Nanoparticle triggered autophagic cell death	1.00000000002084	2.08395115382963e-11	24	0	0	152	5311
WP1539	Angiogenesis	1.00000000002084	2.08395115382963e-11	24	0	0	152	5311
WP262	EBV LMP1 signaling	1.00000000002084	2.08395115382963e-11	24	0	0	152	5311
WP3865	RIG-I-like Receptor Signaling	1.00000000002156	2.15600844455694e-11	61	0	0	152	5311
WP107	Translation Factors	1.00000000002253	2.25301004241753e-11	53	0	0	152	5311
WP363	Wnt Signaling Pathway Netpath	1.00000000002253	2.25301004241753e-11	53	0	0	152	5311
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000002265	2.26535112136812e-11	12	0	0	152	5311
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000002265	2.26535112136812e-11	12	0	0	152	5311
WP2290	RalA downstream regulated genes	1.00000000002265	2.26535112136812e-11	12	0	0	152	5311
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000002265	2.26535112136812e-11	12	0	0	152	5311
WP2516	ATM Signaling Pathway	1.00000000002289	2.28903195446268e-11	40	0	0	152	5311
WP2029	Cell Differentiation - Index	1.00000000002325	2.32492014133149e-11	38	0	0	152	5311
WP707	DNA Damage Response	1.00000000002653	2.65303381449843e-11	69	0	0	152	5311
WP2369	Histone Modifications	1.00000000002653	2.65303381449843e-11	69	0	0	152	5311
WP2355	Corticotropin-releasing hormone signaling pathway	1.00000000002724	2.72360083477364e-11	93	0	0	152	5311
WP1530	miRNA Regulation of DNA Damage Response	1.00000000002724	2.72360083477364e-11	93	0	0	152	5311
WP411	mRNA Processing	1.0000000000282	2.81969858537341e-11	132	0	0	152	5311
WP477	Cytoplasmic Ribosomal Proteins	1.00000000002983	2.98262967314898e-11	90	0	0	152	5311
WP2446	Retinoblastoma (RB) in Cancer	1.00000000003467	3.46658762503161e-11	88	0	0	152	5311
